Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: to the artemisinin component of artemisinin-based combination therapies, the most important malaria drugs, emerged in Southeast Asia and now threatens East Africa. Partial resistance, which manifests as delayed clearance after therapy, is mediated principally by mutations in the kelch protein K13 (PfK13). Limited longitudinal data are available on the emergence and spread of artemisinin resistance in Africa. METHODS: ) and analyzed relatedness using molecular methods. We assessed malaria metrics longitudinally in eight Ugandan districts from 2014 through 2021. RESULTS: By 2021-2022, the prevalence of parasites with validated or candidate resistance markers reached more than 20% in 11 of the 16 districts where surveillance was conducted. The PfK13 469Y and 675V mutations were seen in far northern Uganda in 2016-2017 and increased and spread thereafter, reaching a combined prevalence of 10 to 54% across much of northern Uganda, with spread to other regions. The 469F mutation reached a prevalence of 38 to 40% in one district in southwestern Uganda in 2021-2022. The 561H mutation, previously described in Rwanda, was first seen in southwestern Uganda in 2021, reaching a prevalence of 23% by 2022. The 441L mutation reached a prevalence of 12 to 23% in three districts in western Uganda in 2022. Genetic analysis indicated local emergence of mutant parasites independent of those in Southeast Asia. The emergence of resistance was observed predominantly in areas where effective malaria control had been discontinued or transmission was unstable. CONCLUSIONS: Data from Uganda showed the emergence of partial resistance to artemisinins in multiple geographic locations, with increasing prevalence and regional spread over time. (Funded by the National Institutes of Health.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This mutation was reported in isolates collected in Uganda beginning in 2016.”
From Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia (2025) · cites this paper as [63]
In the citing paper
“It has proven to enhance parasite survival in vitro and has been associated with resistance in vitro63,66.”
From Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia (2025) · cites this paper as [63]
In the citing paper
“These k13 mutations are becoming more common in East Africa in East Africa22,23,62,63.”
From Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia (2025) · cites this paper as [63]
In the citing paper
“The expansion of validated Pfk13 variants adds to growing evidence of ART-R in East Africa8,13,35,36.”
From Genomic surveillance reveals co-occurrence of Plasmodium falciparum drug resistance variants across diverse transmission settings in Ethiopia (2026) · cites this paper as [8]
In the citing paper
“The distinct geographic distributions mirror independent regional emergence seen in Asia and Uganda8,56, suggesting that local drug pressure and genetic background play key roles in shaping ART-R evolution.”
From Genomic surveillance reveals co-occurrence of Plasmodium falciparum drug resistance variants across diverse transmission settings in Ethiopia (2026) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Cited by
Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia
Brhane, B. G., Fola, A. A., Nigussie, H., Leonetti, A., Kassa, M., Hailgiorgis, H., Wuletaw, Y., Abera, A., Mohammed, H., Sime, H., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01008-0 · Cited by 29
Self-citationNayak, S., Peto, T. J., Kucharski, M., Tripura, R., Callery, J. J., Quang Huy, D. T., Gendrot, M., Lek, D., Nghia, H. D. T., van der Pluijm, R. W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54915-6 · Cited by 15
Zeleke, A. J., Fola, A. A., Tollefson, G. A., Niaré, K., Leonetti, A., Taropawala, O., Marglous, J., Crudale, R., Brhane, B. G., Assefa, A., et al. (2025) · PLOS Pathogens · doi:10.1371/journal.ppat.1013771 · Cited by 12
Self-citationLetebo, A., Vanheer, L. N., Engdaw, M., Ejigu, L. A., Hailu Alemayehu, D., Deressa, J. D., Adnew, B., Ayele, A., Bezabih, M. K., Demisse, M., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02420-5 · Cited by 4
Metadata
- Authors
- Conrad, M. D., Asua, V., Garg, S., Giesbrecht, D., Niaré, K., Smith, S., Namuganga, J. F., Katairo, T., Legac, J., Crudale, R. M., Tumwebaze, P. K., Nsobya, S. L., Cooper, R. A., Kamya, M. R., Dorsey, G., Bailey, J. A., & Rosenthal, P. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-08-24
- Volume
- 389
- Issue
- 8
- Pages
- 722-732
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4386117131
- Cited by
- 220
- References
- 1
- FWCI
- 50.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda. https://app.cochat.ai/papers/10.1056/nejmoa2211803
- The paper
- Conrad, M. D., Asua, V., Garg, S., Giesbrecht, D., Niaré, K., Smith, S., Namuganga, J. F., Katairo, T., Legac, J., Crudale, R. M., Tumwebaze, P. K., Nsobya, S. L., Cooper, R. A., Kamya, M. R., Dorsey, G., Bailey, J. A., & Rosenthal, P. J. (2023). Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2211803
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.